Juan Enrique Rozengurt

University of California, Los Angeles

NIH Rank #6857
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#6,857
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 3 grants · National rank #6857.

Top grants by award amount

Juan Enrique Rozengurt's NIH grant portfolio, ranked by award amount.

  • 2R01AI135201-06R01
    The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection
    $747.6K
    award amount
  • 5R01AI173050-02R01
    Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
    $710.7K
    award amount
  • 5P01CA236585-05P01
    Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
    $280.1K
    award amount

Affiliation

Institutions that have administered grants for Juan Enrique Rozengurt.

Affiliated with University of California, Los Angeles (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of California, Los Angeles
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6857